LISA MAYES: Open Payments
NPI 1558651794 · MACON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 40 payments from 21 companies in 2025. Trend: 2023 $754 · 2024 $780 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Amgen Inc. | 6 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| ABBVIE INC. | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Novo Nordisk Inc | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
Products named: REXULTI, CAPLYTA, EVENITY, UBRELVY, AUSTEDO XR, AIRSUPRA, PREVNAR 20, JOURNAVX.
Industry payments across MO — which companies pay providers there.
